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Human Immunodeficiency Virus type 1 (HIV-1) infection causes a growing pandemic 
throughout the world, of which women comprise 51% of people who live with HIV-1, more 
than 60% in sub-Saharan Africa. HIV-1 infections of women are mainly acquired through 
female reproductive tract where cervical and vaginal epithelial cells are the first line of 
defense. Although HIV-1 does not directly infect epithelial cells, HIV-1 obligatorily interacts 
with and crosses over epithelial layer to infect susceptible target cells, mainly CD4+ T cells, 
in the lamina propria to initiate an infection. However, the mechanism and ramification of 
the interaction of HIV-1 and epithelial cells in vaginal transmission of HIV-1 remain to be 
elucidated. We hypothesized that cervical epithelial cells are not a passive barrier, but 
actively respond to HIV-1 to modulate the mucosal milieu and facilitate HIV-1 transmission. 
We tested this hypothesis by studying the responses of cervical epithelial cells to HIV-1 
through profiling genome-wide transcription, analyzing of cytokine and chemokine proteins, 
and confirming some differentially expressed key genes in rhesus macaques model of SIV 
infection. We found: 1) cervical epithelial cells actively respond to HIV-1. Five hundred 
forty-three transcripts/genes in cervical epithelial cells were significantly altered in 
expression at four hours post exposure to HIV-1, of which many relate to important signaling 
pathways, such as innate immune responses, pattern recognition receptors, apoptosis, 
biosynthesis, and energy production, 2) HIV-1 increases the expression of CXC Chemokines 
(IL-8, CXCL1 and CXCL3) in cervical epithelial cells. IL-8 and CXCL1 are potent 
chemotactic for multinuclear neutrophils (MNP), monocytes and a minority of lymphocytes, 
and CXCL3 is predominant chemotactic for monocytes, 3) HIV-1 increases the expression of 
key inflammatory enzymesCOX-1 and COX-2.  COX-1 is responsible for the production of 
prostaglandins that are important for homeostasisi, and COX-2 is a key enzyme to convert 
arachidonic acid to prostaglandins, key inflammatory mediators, and 4) the increased 
expression of IL-8 and COX-2 revealed using microarraywas mapped to the endocervical 
epithelial cells of the macaques intravaginally inoculated with SIV in vivo. Our date lead to a 
role model of epithelial cells in HIV-1 vaginal transmission, that is the axis of HIV-1, 
epithelial cells, proinflammatory molecules (IL-8, CXCL1, CXCL3, COX-1 and COX-2), 
cell recruitment (MNP, monocytes and T cells), and inflammation. This model implies that 
moderating epithelial proinflammatory response to HIV-1 may be a utilityto prevent of HIV-
1 vaginal transmission.
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1CHAPTER 1
Transcriptional analysis of cervical epithelial cell responses to HIV-1
2Introduction
Human immunodeficiency virus type 1 (HIV-1) is a global pandemic that 
disproportionally infects women.  Early events of HIV-1 transmission are not well 
understood, but dictate the course of infection.  The female reproductive tract (FRT) - 
more specifically cervical epithelial cells - is the first barrier to HIV infection.  The 
overarching goal of this research is to investigate cervical epithelial cells and HIV-1 
interaction and better understand the role of cervical epithelial cells in HIV-1 vaginal 
transmission.  The introduction reviews the background of HIV-1 including the 
progression to the acquired immune deficiency syndrome (AIDS), the genetic bottleneck, 
and the role of the female reproductive tract in HIV-1 transmission.
Section I: Background of HIV-1, transmission and pathogenesis
Human immunodeficiency virus (HIV) is classified in the Retroviridae family and 
evolved from primates.  HIV includes type 1 (HIV-1) and type 2 (HIV-2).  Lentiviriae - 
'slow viruses' - are a member of the Retroviridae family and cause slow 
immunodeficiency diseases (Chiu et al.).  Lentiviriae infects a range of mammals 
including ovines, bovines, equines, felines, and primates.  Lentiviriae infecting primates 
are more closely related to each other than to those of other mammals (Myers, MacInnes, 
and Korber 1992).  HIV evolved from Simian Immunodeficiency Virus (SIV).  Primate 
Lentiviriae fall into five groups: (1) HIV-1 & Chimpanzees, (2) HIV-2, Sooty mangabeys 
& Macaques, (3) African green moneys, (4) Mandrills and (5) Sykes' monkeys (Myers, 
MacInnes, and Korber 1992; Emau et al. 1991).  The evolution of the five groups of 
SIV/HIV is not completely understood. 
3HIV contains two strains of positive single-stranded RNA encoding  nine genes 
surrounded by the capsid and a plasma membrane from the host-cell.  HIV attaches to the 
cell CD4 using the Env glycoprotein gp120.  CD4 is found on T helper cells, regulatory T 
cells, monocytes, macrophages, and dendritic cells.  The virus also has two co-receptors: 
C-C chemokine receptor type 5 (CCR5) and C-X-C chemokine receptor type 4 (CXCR4). 
CCR5 normally interacts as a receptor for RANTES, MIP-1β, and MIP-1α.  CXCR4 
normally interacts as a receptor for stromal-derived factor-1.  Once HIV enters the cell, 
the reverse transcriptase transcribes the RNA to DNA in the cytoplasm.  Host factors 
transport the DNA to the nucleus.  The DNA inserts itself into the host genome in random 
locations by integrase.  The integrated copies of DNA serve as templates for RNA 
synthesis.  The virion particles form and bud from the cell.
HIV has three major genetic factors that drive evolution: inefficient coping, 
recombination, and modular evolution.  Reverse transcriptase (RT) is responsible for 
RNA-dependent DNA synthesis and has inefficient proof-reading (Bebenek et al. 1993).  
Single nucleotide polymorphics (SNIPs) from template-primer misalignment, base 
miscoding, or frame shift errors causes variations within HIV-1.  The most variable 
region of HIV is the envelope gene, specifically the V3-V5 region (Lemey, Rambaut, and 
Pybus).  The rate of nucleotide substitution per silent site per year is 10x10-3 for HIV-1 
compared to 10x10-9 in a range of mammals including humans (Wolfe, Sharp, and Li 
1989).  HIV's evolution is about a million times faster than the human genome and at a 
similar rate as influenza A virus (Buonagurio et al. 1986).  HIV-1 is able to go through 
high levels of recombination during replication due to the enzyme dissociation-re-
4association (Zhuang et al. 2002).  Infected cells can have more than one copy of viral 
genome integrated with the host, the average is two, and allowing for more 
recombination (Jung et al. 2002).  Recombination can also occur in the virion, due to the 
two copies carried within the virion.  Modular evolution, the ability to change packages, 
sets of genes, lead to the transformation and evolution of the Lentiviriae (McClure 1996).
HIV-1 is transmitted through the exchange of body fluids by sexual, parenteral, 
and mother-to-child transmission.  Transmission by sexual contact varies from 1 in 10 to 
1 in 3,000 exposures, while mother-to-child is 1 in 4 exposures (Galvin and Cohen 2004). 
Women comprise 51% of people who live with HIV-1 globally, and comprise more than 
60% in sub-Saharan Africa (Sidibé 2010).  Women mainly acquired HIV-1 through 
mucosal surfaces of female reproductive tract (FRT) (Shattock et al. 2008; Brenchley and 
Douek 2008; Hladik and Hope 2009; Hladik, Florian and McElrath 2008).  Paradoxically, 
vaginal transmission of HIV-1 is not efficient and the estimated transmission rate is about 
0.0005 to 0.004 per coital contact (Gray et al. 2001; Wawer et al. 2005). The CCR5-tropic 
HIV-1 strain is more prevalent in North America (Wainberg 2004).
HIV-1 once set a foot in mucosa rapidly spreads throughout the body leaving a 
limited time frame to stop the infection locally.  In ex vivo models and simian 
immunodeficiency virus (SIV) - rhesus macaque models, the virus is able to cross the 
epithelial mucosal in hours (Hu, Gardner, and Miller 2000; Bomsel 1997).  Two to three 
days later, HIV is found in the portal of entry or blood of macaques (C. Miller et al. 
2005).  During transmission, the viruses go through a genomic bottleneck and reduce the 
number of viruses as founder and transmitted viruses.  However, the location and the 
5mechanism of genomic bottleneck has not been fully elucidated.  CCR5 tropism HIV-1 is 
the major viruses establishing a new infection.  The infection becomes entrenched in the 
body 10-14 days later.  The virus reaches peak viral replication around 25 days.  The host 
experiences acute HIV-1 syndrome.  The viral load decreases over time and several 
months later, HIV reaches a steady level of replication or set point.  The long-term 
repercussion of a HIV-1 infection is acquired immune deficiency syndrome (AIDS).  The 
targeted cells, such as CD4+ T cells, are lysed or made nonfunctional and no longer 
respond to foreign pathogens. People usually die from an opportunistic  pathogen 
infection that would be harmless to a healthy immune system or tumor such as Kaposi’s 
sarcoma.
Section II: Genetic bottleneck during HIV-1 transmission
Inter-host transmission poses a genetic bottleneck to Human immunodeficiency 
virus type 1 (HIV-1) viruses (Rambaut et al. 2004).  During the bottleneck, HIV-1 regains 
a homogeneous viral population that resets the evolutionary clock back to the original 
starting point (Stilianakis and Schenzle 2006).  We would expect the virulence of HIV to 
increase overtime without the bottleneck.  The founder population has several 
characteristics which show the evolution of HIV-1 during transmission.  CCR5-tropic 
virus variants dominate early HIV-1  infections (Tersmette et al. 1989).  The phenotype of 
CCR5 virus comes from the V3 domain (De Jong et al. 1992; Fouchier et al. 1992).  
CXC4 tropic virus variants are identified between 24 and 30 months post infection 
(Kuiken et al. 1992).  Viral pathogenesis also relates to  the type of co-receptor used by 
the virus.  Early T-cell tropic viruses contain both CXCR4 and CCR5 receptors (Doranz 
6et al. 1996; Dragic et al. 1996).  Evidence suggests CCR5 is the only co-receptor used by 
HIV-1 during entry, although other transmembrane proteins have been shown to play a 
role in the entry of HIV-1 (Alfsen et al. 2005; Arthos et al. 2008; Bergelson 2009; de 
Witte et al. 2007; Liu, Lingwood, and Ray 1999).  Cytotoxic T-lymphocyte (CTL)  
immune response also shapes intra-host HIV-1 evolution, but does not affect the 
population level (Leslie et al. 2004).  The overall mechanism of inter-host transmission is 
a complicated interaction between  sub-types of the virus and individual immune system.
The evolution sub-subtype mosaic forms of HIV-1 can be classified as 
quasispecies.  When individual variants gain the ability to outcompete the population, the 
virus is driven to extinction by the immune system.  The high turn over of HIV-1 can lead 
to mutations and phenotype changes.  The different quasispecies also lead to parallel 
evolution, allowing  for more successful variants to dominate at one time .  The intra-host 
evolution is based on the community, not just the individual virion.
The transmission of HIV-1 from donor to recipient causes evolutionary changes in 
the viral variant depending on the transmission method.  The first transmission method is 
a direct passage of variants (Takahashi et al. 1989; Siliciano and Guthrie 1988; Palker et 
al. 1988; Looney et al. 1988).  Donor variants escape immune surveillance, and when 
transmitted, the variants have survival advantages.  Another transmission method is when 
a limited number of the majority variants in the donor are transmitted and within-host 
selection causes the majority to become the minority (Wolinsky et al. 1992; Mano and 
Chermann; Courgnaud et al. 1991).  Third, the donor may have a minority variant that 
has selective advantages in cell tropism, co-receptors, or replication capacities and allow 
7the variant to become the majority in the recipient (Zhu et al. 1993; Connor and Ho 
1994).  Each of these methods supports the selection of a particular variation based on 
phenotype for intra-host evolution.
Section III: The role of the female reproductive tract in HIV-1 transmission
The female reproductive tract (FRT) can be divided into two major compartments 
(Hladik, Florian and McElrath 2008).  The lower tract consists of the vaginal and 
ectocervix and the upper track consist of endocervix, uterus, and fallopian tubes.  The 
mucosal membranes are divided into two different types: type I and type II (Iwasaki 
2007).  The lower tract consists of multi-layered squamous epithelium, type II; whereas 
the upper tract contains a single layer columnar epithelium, type I.  The multiple layers of 
epithelial cells in the ectocervix and vagina provide better mechanical protection than that 
of the single layer in endocervix, although the vaginal wall and ectocervix has a greater 
surface area compared to the endocervix.  Several lines of evidence indicate Human 
immunodeficiency virus type 1 (HIV-1) preferentially gains entry of FRT through the 
endocervix (C. Miller et al. 2005; Zhang et al. 1999; Q. Li, Estes, et al. 2009).
The low efficiency of HIV-1 vaginal transmission indicates that cervicovaginal 
mucosal tissue including epithelial cell lining provides a robust barrier to HIV-1 
infections. Thus HIV-1 vaginal transmission is a complex process of HIV-1 overcoming 
host defenses.  Mucus is secreted into the lumen of the FRT to trap or delay HIV-1 and 
other microorganisms from gaining access to the epithelial cells (Lai et al. 2009).  Anti-
HIV-1 proteins secreted by epithelial cells into the lumen include Beta-defensins, 
Trappin-2/Elafin, CCL20/MIP3α, Serine Protease Inhibitor Secretory Leukocyte Protease 
8Inhibitor (SLPI), and LL-37 (Sun et al. 2005; Zapata et al. 2008; Ghosh et al. 2010; 
Levinson et al. 2009; McNeely et al. 1997; Wahl et al. 1997; Bergman et al. 2007).  Since 
the epithelial cells of cervix and vagina are the first line of defense, HIV-1 obligatorily 
interacts with and crosses over in order to gain access to submucosal target cells to 
initiate an infection. Once in the laminar propria, HIV-1 has to find a small set of CD4+ T 
cells to initiate an infection, but the precise role of dendritic cells (DCs) and macrophages 
in vaginal transmission remains controversial (Shen, Richter, and Smith 2011; Haase 
2010).  
Despite recent efforts and progress made in understanding the acute events 
following HIV-1 vaginal transmission, how HIV-1 interacts with epithelial cells, and 
what  role this interaction may play in HIV-1, vaginal transmission remain incompletely 
understood.  Further, the mechanisms of how HIV-1 crosses the epithelial barrier remain 
undefined (Shattock and Moore 2003).  Four plausible mechanisms are proposed to 
explain how HIV-1 crosses epithelial cells.  First, HIV-1 gains access to susceptible target 
cells in mucosa via a damaged epithelial barrier.  Second, HIV-1 is transported through 
the mucosal barrier by dendritic cells (de Witte et al. 2007).  Lawrence et al suggested 
monocytes preferential transmit CCR5-tropisms (Lawrence et al. 2012).  Both of these 
models are difficult to test and does not explain results described below.  Third, HIV-1 
could contact epithelial cells, causing changes within the epithelial cells.  HIV-1 interacts 
by some unknown mechanism with those cells to down regulate tight junction proteins 
allowing HIV-1 and other microorganisms to pass through the submucosa (Nazli et al. 
2010).  Fourth, HIV-1 is transcytosis - the process by which HIV-1 is transported across 
9the interior of a epithelial cell by endosomes, and is released on basolateral  side.  Both 
ex vivo cervico-vaginal culture model and  transformed epithelial cells in transwells have 
been used to study transcytosis (Bomsel 1997; de Witte et al. 2007; Maher et al. 2005; 
Collins et al. 2000).  Intestinal epithelial cells have also been shown to transcytosis HIV-1 
indicating a common mechanism (Meng et al. 2002).  
Conversely, some in vitro studies showed HIV-1 could productively infect 
epithelial cells, but there is no convincing in vivo evidence to support that (Tan, Pearce-
Pratt, and Phillips 1993).   Many different surface proteins are suggested in  HIV-1 and 
epithelial cell interactions: salivary agglutinin (SAG) glycoprotein gp340, beta 1 integrin, 
epithelial cell sulfated lactosylceramide,  integrin alpha4 beta7, syndecans and 
intercellular junctions (Alfsen et al. 2005; Arthos et al. 2008; Bergelson 2009; Bobardt et 
al. 2007; Stoddard et al. 2007b).  HIV-1  may interact with several of these proteins at the 
same time or one of these proteins and/or other an unidentified protein.
Studies of Rhesus macaque (Macacca mulatta)/ Simian Immunodeficiency Virus 
(SIV) model of HIV-1 vaginal transmission suggested that HIV-1 may interact with 
cervical epithelial cells to trigger an “outside-in" chemokine signaling cascade to recruit 
CD4+ T cells into submucosa and facilitate HIV-1 infection (Q. Li, Estes, et al. 2009).  
However, this study has not directly evaluated the interaction of HIV-1 and epithelial 
cells.  Research shows Interleukin 6 (IL-6), IL-8, IL-1Ra, MIP-1α, CCL20/MIP3α, MCP-
1, RANTES, TNF-α, INF-α, and INF-γ can be induced in the cervix from 3 to 10 days 
post SIV infection.  Nazli et al used mono-layer of epithelial cells, but only tested six 
different cytokines (Nazli et al. 2010).  Katsikis et al and Abel et al infected rhesus 
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macaques and isolated mRNA from tissue samples to identify changes in cytokines, but 
homogenized complex mucosal tissues cannot discern altered genes in expression 
(Katsikis, Mueller, and Villinger 2011; Abel et al. 2005).  Jespers et al used 
cervicovaginal lavage samples from highly exposed, limited exposure or no exposure to 
HIV-1 to identify changes in cytokines and chemokines (Jespers et al. 2011).  Jespers' 
study is limited by not knowing the direct cause of the changes in expression.  Overall, 
these studies are limited in numbers of cytokines and chemokines tested and where the 
cytokines were derived.  Additionally, conflicting results have been found on the different 
expression levels and time post HIV-1/SIV infection.
Section IV: Hypothesis and goals
HIV-1 transmission in women is a major problem worldwide. During 
transmission, HIV-1  interacts with epithelial cells lining cervicovaginal tract and crosses 
this first line of defense. We hypothesize cervicovaginal epithelial cells actively respond 
to the presence of HIV-1 during HIV-1 vaginal transmission.  We tested the hypothesis by 
(1) measuring cytokines and chemokines proteins levels, (2) profiling genome-wide 
transcription and (3) confirming some differentially expressed key genes in rhesus 
macaques model of SIV infection. This study underscores the importance of epithelial 
cells in HIV-1 vaginal transmission and suggests that modulating epithelial cell responses 
to HIV-1 may be a new target for preventing HIV-1 vaginal transmission.
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Methods and Materials
Cervical Epithelial Cells and HIV-1
Human endocervical epithelial cells, CRL-2615, were obtained from ATCC and 
maintained in keratinocyte-serum free ATCC complete media.  The cells were cultured in 
six well plates and incubated over 48 hours to ensure attachment to the plate, and then the 
media was removed and fresh media containing CCR5 tropism HIV-1ME1 at 0.2 TCID50 
per cell were added. HIV-1ME1 was obtained from Dr. Phalguni Gupta through the AIDS 
Research and Reference Reagent Program, Division of AIDS, NIAID, NIH (Chen et al. 
1997).  Cells in fresh media without adding HIV-1 were used as a control. The cells and 
supernatant from both HIV-1 treated and control cultures were collected at 0, 4, 6, 12 and 
24 hours post HIV-1 exposure.  The supernatant was centrifuged at 1000 rpm for 6 
minutes and the total volume was measured and frozen at -80°C until analysis.  The cells 
were rinsed with 0.25% trypsin, 0.53 mM EDTA solution, and detached by incubating at 
37°C with 0.1M trypsin-EDTA solution. The trypsin was neutralized by adding a 1:1 
mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium containing 10% 
fetal bovine serum.  The cell pellet was collected after centrifugation at 1000 rpm for 6 
minutes and placed at -80°C until use.  The viral stock suspension was separated from the 
viral stock by centrifugation at 10,000 rpm for 60 minutes (Iordanskiy and Bukrinsky 
2009).  The suspension was added and processed similar to the viral stock.
Cytokine, Chemokine and growth factor analysis
Cytokine Human 30-Plex Panel (Catalog number: LHC6003, Invitrogen) 
quantified thirty cytokine, chemokine and growth factor proteins, following the 
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manufacturer's instructions. Briefly, samples were diluted using a 1:1 mixture of assay 
dilutant and media.  Each sample contained three replicates with one technique replicate.  
The panel was read on a Bio-Plex 200 System using Bio-Plex Manager software version 
4.0 (Bio-Rad, Hercules, CA). The calibration curves were generated using the kit 
standards.  IL-6, IL-8, IL-1Ra, and MIP3α were quantified using Quantikine human 
Enzyme-linked immunosorbent assay (ELISA, R&D Systems, Minneapolis, MN) 
according to the manufacturer’s protocol.  Statistical analysis was conducted with 
SigmaPlot (San Jose, CA).  The samples were normalized to the amount of supernatant 
collected for each sample. Any measured level below the sensitivity of the individual 
cytokine detection was considered as a zero.
Quantitative real-time reverse transcriptase polymerase chain reaction
Gene expression quantifications were performed using qRT-PCR and reported 
according to MIQE guidelines (Bustin et al. 2009).  Qiagen mRNA purification kit 
(Valencia, CA) extracted and purified mRNA.  Melting curve analysis was performed at 
the end of each run to check for primer dimers.  Four target genes were selected from the 
microarray data, and the primers were selected from the RTPrimer database (table 1) 
(Birkenkamp-Demtroder et al. 2002; Johnson et al. 2002; Lefever et al. 2009; 
Vandesompele et al. 2002).  The cDNA was synthesized and quantified was conducted 
with iScriptTM One-step RT-PCR kit with SYBR® Green (Bio-Rad) with the program: 
50°C 10 min, 95°C 5min, and 40 cycles of 95°C 10 sec, and 55°C 30sec.  Data analyses 
were conducted using Biogazelle qbasePLUS version 2.3 (Hellemans et al. 2007).  Briefly, 
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quantification cycle (Cq) values were converted into relative expression values taking 
into account amplification efficiency, and the relative expression values were normalized 
using GAPDH as a reference gene.  Calibrated Normalized Relative Quantity values were 
exported from the qbasePLUS software and statistically analyzed using SigmaPlot.
RNA extraction and microarray    
The genome-wide transcriptional responses in epithelial cells exposed to HIV-1 
were analyzed using human microarrays (Human Genome U133 Plus 2.0 Array, 
Affymatrix, Santa Clara, CA).  Cells at four hours post HIV-1 exposure and the un-
exposed control, in duplication, were analyzed. mRNA was extracted and purified using 
the Qiagen mRNA purification kit (Valencia, CA).  The mRNA (15ng) was amplified and 
labeled with biotin using Ovation WGA System and Ovation Pico WTA System 
(NuGEN, San Carlos, CA).  The Genomics Core Research Facility of the University of 
Nebraska –Lincoln labeled and hybridized the cDNA to microarray per the 
manufacturer’s instructions.  The signals on the chips were scanned with the Affymetrix 
GCS 3000 7G scanner and GeneChip Operating Software.  
Data normalization and statistical analysis
  Data normalization and statistical analysis were based on  published methods 
(Gillespie et al. 2010).  Briefly, raw microarray data were processed and analyzed using 
Affy and Lumma packages of Bioconductor, an R package 
(http://www.bioconductor.org/, http://www.r-project.org/).  The backgrounds were 
corrected with Robust Multiple-array Average (RMA).  Significance of differential 
14
expressed genes in controls and HIV-1 exposed group were compared with a moderated t-
statistic.  Significantly altered genes in expression were defined as a log 2 fold change of 
> 1 or < 1 and P <0.05,  and were annotated and assigned biological function using the 
Database of Annotation, Visualization and Integrated Discovery (DAVID) 
(http://david.abcc.ncifcrf.gov/home.jsp) and Ingenuity Pathways Analysis ( Ingenuity 
Systems,  http://www.ingenuity.com/ ).  All microarray data has been deposited in the 
NCBI's Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/gds; accession 
number GSE42291).
Mapping IL-8 and COX-2 to the cervical epithelial cells of Indian rhesus macaques
Five adult female Indian rhesus macaques (Macaca mulatta) were intravaginally 
inoculated with SIVsmB7, a non-infectious virus-like particle (VLP), twice daily for 3 days. 
The macaques were euthanized on the 4th day post inoculation. The cervix was collected 
and fixed in 4% paraformaldehyde and embedded in paraffin for sectioning at 6 microns 
(Kraiselburd and Torres 1995).  Immunohistochemical staining of IL-8 and COX-2 were 
conducted using previously published protocol (Q. Li, Smith, et al. 2009).  Antibodies 
against IL-8 (clone Ab7747, 1:50, Abcam) and COX-2 (clone CX-294, 1:25, Dako) were 
used and with an isotope control IgG as the negative control. Staining was detected and 
visualized using the Dako Envision Polymer kit and 3, 3-Diaminobenzidine (DAB) as 
substrate.
15
Results
Measurement of cytokine, chemokine and growth factor proteins
We measured the interactions of HIV-1 with cervical epithelial cells at protein 
level.  Cervical epithelial cells, CRL-2615, were exposed to HIV-1ME1, and the supernatant 
of cultures was collected at 0, 4, 6, 12, and 24 hours post HIV-1 exposure. Out of the 30-
Plex panel, eight proteins (IL-6, IL-8, IL-1Ra, RANTES, IL-13, IP-10, VEGF and MIL-
1α) from HIV-1 exposed cervical epithelial cells changed expression over the time course 
in comparison with that of control epithelial cells (Figure 1).  We used ELISA to: 1) 
confirm the Bio-plex results and 2) measure CCL20/MIP3α, which was not included in 
the 30-Plex panel. There were more prominent changes at four hours post exposure than 
at other time points. Interleukin 6 was significantly up regulated at four hours, but not at 
any other time points (t = -3.648, d.f. = 4, p = 0.022, Figure 2a).  Three proteins increased 
at four hours, but not significantly:  IL-8 (t = -1.997, d.f. = 4, p = 0.116, Figure 2b),  IL-
1Ra (t = -2.535, d.f. = 3, p = 0.056, Figure 2c), and CCL20/MIP3α (t = -1.158, d.f. = 4, p 
= 0.311, Figure 2d).  
Global gene expression measurement using human microarray
The epithelial cells at four hours post HIV-1 exposure changed more than at any 
of the other time points based upon the results of human 30-Plex and ELISA.  We 
selected four hours to conduct genome-wide transcriptional analysis of epithelial cells 
response to HIV-1 using the Affymetrix human microarray. The gene expression in HIV-1 
exposed epithelial cells was compared to that of epithelial cells without HIV-1 exposure.  
The microarray showed 574 altered expression out of 54,675 transcripts/genes (213 up 
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regulated and 361 down regulated). Based on functional annotation from DAVID and 
extensive examination of published literature, we were able to classify ~55% (314) of the 
altered genes in expression (Figure 3 and 4, Table 2).  The microarray results were 
validated using qRT-PCR (Figure 5).  We exclude the possibility that the altered genes in 
expression in epithelial cells exposed to HIV-1 were caused by other factors, such as 
growth factors in culture media used in virus stock preparation rather than HIV-1.  The 
viral stock supernatant was separated from virus using centrifugation.  The analysis of the 
supernatant for its effects on the epithelial cells detected no significant difference in gene 
expression compared to that of controls (Figure 5).
Of the classifiable altered genes in expression, ~7% (23) are related to innate 
immune function. Proinflammatory chemokine IL-8 - one of the major mediators of the 
inflammatory response and a chemoattractant for MNP, monocytes and T cells - was 
significantly upregulated, which is in concurs with the increase at protein level revealed 
by Bio-Plex assay (Figure 1b). Other proinflammatory chemokine, CXCL1 and CXCL3, 
were also significantly upregulated.   CXCL1 and CXCL3 are chemoattractants for MNP 
and monocytes respectively.  COX-1 and 2 -rate-limiting enzymes for prostaglandins 
production and key mediators for inflammation- were upregulated.  Another 
inflammation related molecule CD55, a complement pathway regulator, was also 
upregulated.  Furthermore, genes encoding toll-like receptor regulators were 
downregulated (TIRAP, IL1-RL1 & IRAK2).  Toll-interleukin 1 receptor (TIR) domain 
containing adapter protein (TIRAP) is involved in TLR2 and TLR4 signaling pathways in 
innate immune response.  Interleukin 1 receptor-like 1 (IL1-RL1) is a member of the 
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Toll-like receptor superfamily and receptor for IL-33.  Interleukin-1 receptor-associated 
kinase 2 (IRAK2) binds to the IL-1 type I receptor following IL-1 engagement to trigger 
intracellular signaling cascades.  TRIM6 (Tripartite motif-containing protein 6) and 
S100A8, known antiviral peptides, were significantly down regulated. Four transcripts of 
genes related to phagocytosis were significantly altered in expression (three upregulated 
and one downregulated).  Of note, RAB7 (Ras-related protein Rab-7a), an important 
molecule in the late endocytic pathway, was upregulated; ELMO3 (engulfment and cell 
motility 3), involving in cytoskeletal rearrangements required for phagocytosis, was 
downregulated. In concurrency with innate immune genes alteration in expression, 
Ingenuity Pathway Analysis revealed the activation of  Jak/Stat canonical pathway, 
known for regulating interferon, interleukin, growth factors, or other chemical 
messengers (Figure 6b).
DAVID indicated ~4% (13) of classifiable altered genes in expression relate to 
epithelial cells (Figure 4), including epithelial membrane protein 1, keratinocyte growth 
factor-like protein 2, epithelial membrane protein 1 and endothelin 1.  IRF6 (interferon 
regulatory factor 6), a key regulator for the keratinocyte proliferation-differentiation, was 
upregulated.  The genes (19, 8 up regulated) related to cytoskeleton organization were 
altered in expression. The genes encoding membrane bound proteins were downregulated 
and genes encoding cell-to-cell adhesion proteins (11, 7 up regulated) were altered in 
expression.  This indicates epithelial cells changing their internal and external structure in 
the presence of HIV-1.  Most ubiquitin genes are downregulated, but genes encoding 
SMAD specific E3 ubiquitin protein ligase 2 and calcyclin binding protein were 
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upregulated (11, 4 up regulated).  In addition, genes related to cell cycle (~11%), 
apoptosis (~3%) and some transcription factors (~16%) were altered in expression 
(Figure 6c).  
 Biosynthesis was the largest group of altered genes in expression (~24%, 74) 
(Figure 4), a process of synthesis of tRNAs and the production of and regulation of 
energy within the cell.  Major categories with biosynthesis are GTP production, glucose 
metabolic process, ion binding, membrane lipid biosynthetic process, sulfur metabolism 
and sphingoid metabolic process.  The genes of sphingoid metabolic process were 
upregulated, including sphingomyelin synthase 1, sphingomyelin synthase 2, UDP-
glucose ceramide glucosyltransferase and sialidase 3.
Mapping IL-8 and COX-2 proteins to the endocervical epithelial cells of rhesus 
macaques
We tested whether the altered IL-8 and COX-2 genes expression are relevant in 
vivo using immunohistochemical staining.  Adult female Indian rhesus macaques were 
intravaginally inoculated with inactivated SIV.  We found that both IL-8 and COX-2 were 
expressed in the cervical epithelial cells in addition to the cells in the lamina propria, 
(Figure 7).
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Discussion
Women, especially in sub-Saharan Africa, are disproportionally impacted by HIV-
1 infections, which are mainly acquired through vaginal transmission. The interplay 
between HIV-1 and its host at cervicovaginal mucosal surfaces, where epithelial cells are 
the first line of defense, ultimately determine the outcomes of infection or protection. 
Although epithelial cells are not directly infected by HIV-1, its interactions with HIV-1 
are prerequisite for HIV-1 to establish vaginal transmission.  However, the interaction of 
epithelial cells and HIV-1 remains incompletely understood and the epithelial cells are 
thought to function only as a passive barrier in HIV-1 infection (Stoddard et al. 2007a; 
Bouschbacher et al. 2008; C. J. Miller and Shattock 2003).  To better understand the 
interaction of cervical epithelial cells and HIV-1 and its role in HIV-1 vaginal 
transmission, we studied genome-wide transcriptional responses of cervical epithelial 
cells to HIV-1.
We found that cervical epithelial cells actively respond to HIV-1. We found 574 
transcripts/genes (213 upregulated and 361 downregulated) were altered in expression in 
the epithelial cells at 4 hours post HIV-1 exposure (Figure 3) indicating cervical epithelial 
cells are not a passive barrier, but play an active role in HIV-1 vaginal transmission.
Strikingly, ~7% (23 transcripts/genes) of classifiable, altered genes are related to 
innate inflammatory immune response (Figure 4).  Our results demonstrated that HIV-1 
can increase the expression of  IL-8 , CXCL1 and CXCL3 in cervical epithelial cells.  IL-
8 and CXCL1 are potent chemotactic for MNP, monocytes and a minority of lymphocytes 
(Bouschbacher et al. 2008).  CXCL3 is predominant chemotactic for monocytes (Smith et 
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al. 2005).  It has been shown that IL-8 enhances HIV-1 replication in macrophage and T 
cells and increase susceptibility of cervical tissue to HIV-1 infection (Lane et al. 2001; 
Narimatsu, Wolday, and Patterson 2005).  Elevated cervical IL-8 correlated with 
increased HIV-1 shedding in female reproductive tract (Gumbi et al. 2008).   
Furthermore, it has been shown that mononuclear phagocytes (MNP) transepithelial 
migration mediates epithelial injury, comprises barrier function and enhances luminal 
pathogen such as HIV-1 to cross epithelial barrier (Chin and Parkos 2007).  IL-6 was 
upregulated within the microarray data, but not significantly.  The difference between the 
results is currently not known.  Our data suggest the recruitments of cells (MNP, 
monocytes and T cells) through the upregulation of  CXC Chemokines by cervical 
epithelial cells that is triggered by HIV-1, may play a key role in HIV-1 vaginal 
transmission.  
Concomitantly, cyclooxygenase (COX)- 1 and -2 genes were upregulated in 
expression. COX-1 is responsible for the production of prostaglandins (PG) that are 
important for homeostatic functions (Crofford 1997).  COX-2 is a key enzyme to convert 
arachidonic acid to prostaglandins, key inflammatory mediators. It has been demonstrated 
that COX-2 is upregulated during various inflammatory conditions (Martel-Pelletier, 
Pelletier, and Fahmi 2003; Chang et al. 2003; Morton and Dongari-Bagtzoglou 2001; 
Tsujii and DuBois 1995). It was previously demonstrated that COX-2 was upregulated in 
the presence of vaginal topic contraceptive microbicide, Nonoxynol-9, a well-known 
agent inducing cervicovaginal mucosal inflammation and damage (Zalenskaya et al. 
2011).  The clinic trials of Nonoxynol-9 as vaginal topical microbicide showed it 
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increased HIV-1 vaginal transmission (Pettersen et al. 2011).  Furthermore, increased 
prostaglandins from epithelial cells may activate adjacent T cells and monocytes in 
submucosa, since it has been demonstrated that COX-2 contributes to immune activation 
during HIV-1 infection (Pettersen et al. 2011).  Chronic HIV-1 infection is associated 
with significantly increased COX-2 in cervical cells collected using cytobrush compared 
that of HIV-1 uninfected women (Fitzgerald et al. 2012).  Our data extended these results 
and unambiguously showed that cervical epithelial cells increase COX-2 expression after 
exposure to HIV-1.  COX-1 and 2 are key in initiating and amplify mucosal 
inflammation, thus moderating mucosal inflammation by selectively inhibiting COX-2 
using non-steroidal anti-inflammatory drugs is worthy to further explore.  
Ingenuity Pathway Analysis revealed that Jak/Stat canonical pathway, known for 
regulating interferon, interleukin, growth factors, or other chemical messengers, was up 
regulated (Fig 6b).  The Jak/Stat pathway has been shown to be important in HIV 
infections  (Wang et al. 2010).  Concurrently, with increased expression of 
proinflammatory innate immune genes, four genes related to phagocytosis were 
significantly altered in expression, of note, RAB7 (Ras-related protein Rab-7a), an 
important molecule in the late endocytic pathway, was upregulated; and ELMO3 
(engulfment and cell motility 3), involving in cytoskeletal rearrangements required for 
phagocytosis, were downregulated.
The transcriptome analysis also showed alternations of genes related to 
biosynthesis and life cycle of the epithelial cells.  Biosynthesis is an important part of the 
interactions of HIV-1 and epithelial cells. Sphingoid metabolic process is the synthesis of 
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lipids and other compounds associated with lipid rafts. Recent studies have shown that 
lipid rafts are important to the entry and budding of HIV-1 (Fantini et al. 2004; Clayton 
et al. 2001).  Our results showed an increase in transcripts in sphingoid metabolic 
process, but the role in HIV-1 transmission is unknown.
The internal and external structure of epithelial cells creates a barrier to 
pathogens.  Our results show a loss of alterations in the structure of the epithelial cells.  
The loss of receptors and alterations of the internal and external structure may indicate 
significant tissue rearrangement.  The lost of tight junction proteins may allow gaps in the 
epithelial barrier allowing HIV-1 to past the barrier without infecting the cells (Nazli et 
al. 2010).  Actin and cytoskeleton play an important part in the assembly and 
transmission of HIV-1 (Matarrese and Malorni 2005).  Alterations in the cytoskeleton 
can lead to apoptosis.  Although our results do not indicate apoptosis; further study needs 
to be done on the effects the alteration of the internal and external structure has on the 
entrance of HIV-1.
Some anti-HIV-1 molecules, such as TRIM5α, Tetherin, LL-37, trappin-2, and 
CCL20/MIP3α, are naturally expressed by epithelial cells and may increase in expression 
in the presence of HIV-1 (Ghosh et al. 2010; Neil, Zang, and Bieniasz 2008; Perez-
Caballero et al. 2009; Bergman et al. 2007; Levinson et al. 2009; Ghosh et al. 2009).  
CCL20/MIP3α has also been shown as anti-HIV-1 peptide secreted into the lumen of the 
cervix (Ghosh et al. 2009).  Our results showed the down regulation of TRIM6 and 
S100A8, known antiviral peptides.  TRIM6 is associates with HIV-1 virion, but does not 
show inhibition like TRIM5α (X. Li et al. 2007; X. Li et al. 2006).  S100A8 has not been 
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shown to effect HIV-1, but has been shown to be important to Human Papillomaviruses 
18 (Lo et al. 2007).  Drannik et al. suggested trappin-2  has an inhibitory effect on HIV-1 
by altering epithelial cell surface proteins (Drannik et al. 2012).  Trappin-2 reduce 
activation of NF-kB, AP-1, RIG-I, and MDA5 (Henriksen et al. 2004; Drannik, Henrick, 
and Rosenthal 2011).  Our results show an increase in , indicating trappin-2 is not 
functioning with the epithelial cells.  We speculate increasing the expression of the anti-
HIV-1 molecules or stopping the downregulation will help prevent HIV-1 transmission.   
Our results lacked some genes that have been previously found.  Trappin-2 
downregulates activation of NF-kB, AP-1, Retinoic acid-inducible gene 1 (RIG-I), 
Melanoma differentiation-Associated protein 5 (MDA5) (Henriksen et al. 2004; Drannik, 
Henrick, and Rosenthal 2011).   Our results matched an increases in trappin-2, but we did 
not find changes in any of the other proteins.  Past studies used HeLa cells or TZM-bl 
cells; theses cells are a cancer line and do not represent cervical epithelial cells.  We used 
a cell line created by inoculating the cells with viral oncogenes.  The cells are closer to an 
accurate representation of cervical epithelial cells, and are easy to culture and manipulate. 
We did not test if the cells could be infected by HIV-1. Our intentions were to study the 
effect of HIV-1 on epithelial cells - not HIV-1 transmission by the epithelial cells. 
Our data and previously published works provides a model  for the interactions 
between epithelial cells and HIV-1 in vaginal transmission.  HIV-1 interacts with the 
epithelial cells by some unknown surface protein and is recognized as a pathogen.  The 
epithelial cells induce pro-inflammatory molecules (IL-8, CXCL1, CXCL3, COX-1 and 
COX-2) triggering cell recruitment (MNP, monocytes and T cells) and inflammation.  
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The inflammation and alterations within the epithelial cells causes changes in the cell and 
tissue structure possibly allowing for HIV-1 access to the sub-mucosa.
In summary, our study has gained new insights into the interaction of HIV-1 and 
cervical epithelial cells. We found 1) cervical epithelial cell actively respond to HIV-1, 2) 
HIV-1 increases the expression of CXC Chemokines (IL-8, CXCL1 and CXCL3) in 
cervical epithelial cells, 3) HIV-1 increases the expression of key inflammatory enzymes-
COX-1 and COX-2, and 4) the increased expression of IL-8 and COX-2 revealed using 
microarray analysis was mapped into the endocervical epithelial cells of macaques 
inoculated with inactivated SIV in vivo (Figure 6). Our data lead to a role model of 
epithelial cells in HIV-1 vaginal transmission, that is an axis of HIV-1, epithelial cells, 
proinflammatory molecules (IL-8, CXCL1, CXCL3, COX-1 and COX-2), cell 
recruitment (MNP, monocytes and T cells), and inflammation. This model implies that 
moderating epithelial proinflammatory response to HIV-1 may be utilized in prevention 
of HIV vaginal transmission.
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Figure 1. Protein measurements in the supernatant of cultured cervical epithelial cells at 
different time points post HIV-1 exposure using Cytokine Human 30-Plex Panel. 
Attached human endocervical epithelial cells-CRL-2615 were cultured and exposed to R-
5 HIV-1ME1 at 0.2 TCID50 per cell. The supernatant from both HIV-1 treated and control 
cultures were collected at 0, 4, 6, 12 and 24 hours post HIV-1 exposure. Thirty cytokine, 
chemokine and growth factor proteins were quantified using Cytokine Human 30-Plex 
Panel. Eight proteins (IL-6, IL-8, IL-1Ra, RANTES, IL-13, IP-10, VEGF and MIL-1α) 
from HIV-1 exposed cervical epithelial cells showed alteration over the time course in 
comparison with that of control epithelial cells.  a) IL-6,  b) IL-8,  c) Il-1Ra,  d) 
RANTES,  e) IL-13,  f) IP-10,  g) VEGF,  and h) MIL-1α
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Figure 2. Quantified Proteins in the supernatant of cultured cervical epithelial cells at 4 
and 6 hours post HIV-1 exposure using ELISA. IL-6 was significantly upregulated at four 
hours post HIV exposure (t = -3.648, d.f. = 4, p = 0.022, part a).  IL-8 (t = -1.997, d.f. = 4, 
p = 0.116, part b), IL-1Ra (t = -2.535, d.f. = 3, p = 0.056, part c) and CCL20/MIP3α (t = 
-1.158, d.f. = 4, p = 0.311, part d) increased, but not significantly.  The black bars 
represent the control and the gray bars represent epithelial cells exposed to HIV-1.
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Figure 3.  Heatmap of significantly altered 574 transcripts/genes in expression from the 
cervical epithelial cells at four hours post HIV-1 exposure using Affymetrix Human 
Genome microarray.  
mRNA was extracted from the cultured cervical epithelial cells at 4 hours post R-5 HIV-
1ME1 at 0.2 TCID50 per cell, amplified and labeled with biotin. The labeled cRNA was 
hybridized to microarray chip data normalization and statistical analysis was based on 
published methods .  
Significantly altered genes in expression were defined as a log 2 fold change of > 1 or < 1 
and P <0.05 in comparison with that of control epithelial cells.  
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Figure 4.  Functional classification of some significantly altered genes in expression 
from epithelial cells at 4 hours post HIV-1 exposure.  A total of 574 transcripts/genes 
were significantly altered in expression, of which 314 genes can be classified (lfc = 1, p 
value = 0.05). The size of each sector in the pie diagram is proportional to the number of 
genes in the corresponding category. The numbers of altered genes and upregulated genes 
in expression for each category are shown in parentheses. All the gene names, 
abbreviations, log-fold change and p-values can be found in Table 2.  
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Figure 5.  Detection of select genes in cervicovaginal epithelial cells inoculated with 
HIV-1.  Data expressed as fold-change of cellular gene expression based on GAPDH 
gene with standard deviation based on three replicates with a technical replicate.  
Asterisks indicate statistically significant differences using an one way ANOVA and 
Holm-Sidak post-hoc analysis (p < 0.05).
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Figure 6. Significantly activated signaling pathway and networks. Pathway and networks 
of significantly altered genes in expression were generated using the Ingenuity Pathways 
Analysis software. a) the network of inflammatory response, b) Jak/Stat canonical 
pathway and c) the network of cellular development, proliferation & death. Red indicates 
genes significantly increased in expression, green indicates genes significantly decreased 
in expression, and black indicates no significant change in gene expression.
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Figure 7. Photogram of IL-8 (A) and COX-2 (B) expression in the endocervical 
epithelial cells of Indian rhesus macaques (Macaca mulatta) after intravaginal inoculation 
of inactivated SIV. The enlarged photograms are from the rectangular boxes of whole 
cervical sections.  Red arrows indicates detected positive signals in epithelial cells.  Scale 
bar equals 50 microns.
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